EUVIMEDEUVIMED entdecken
Fallbericht

Sustained Virologic Response Following a Shortened Course of Direct-Acting Antiviral Therapy in an HIV/HCV Co-Infected Patient With Previous Treatment Experience: A Case Report

Natasha Bhutani iD, Yoona Lee iD, Maria A Longo iD, Leonard Berkowitz

Journal of Pharmacy Practice · 2025

DOI: 10.1177/08971900251408942 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Pharmacy Practice, 2025. Verfasst von Natasha Bhutani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacotherapy, The Brooklyn Hospital Center, Brooklyn, NY, USA. Hauptthemen laut MEDLINE: Antiviral Agents, HIV Infections, Carbamates, Hepatitis C, Chronic. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We describe a 47-year-old treatment-experienced African-American man co-infected with human immunodeficiency virus (HIV) and chronic hepatitis C virus (HCV) who took sofosbuvir-velpatasvir-voxilaprevir (SOF/VEL/VOX) for approximately 4 weeks and achieved sustained virologic response 12 weeks post-treatment (SVR12). Prior to initiating SOF/VEL/VOX, the patient completed 10 weeks of treatment with SOF/VEL. After 1 month of SOF/VEL/VOX, the patient was lost to follow-up for 3 months. This case report illustrates that SVR12 may be achieved in treatment-experienced patients living with HIV/HCV who complete a shortened duration of triple-direct acting antiviral therapy. Healthcare professionals should consider obtaining an HCV-RNA to assess if SVR12 was achieved prior to re-initiating treatment in patients lost to follow-up or who did not complete therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsHIV InfectionsCarbamatesHepatitis C, ChronicSustained Virologic ResponseHeterocyclic Compounds, 4 or More RingsCoinfectionHumansMiddle AgedMaleSofosbuvirSulfonamidesCyclopropanesMacrocyclic CompoundsTreatment OutcomeTime FactorsDrug Combinations

Stichwörter der Autor:innen

HIVHIV-HCV coinfectiondirect-acting antiviral therapyhepatitis Csofosbuvir-velpatasvir-voxilaprevir

Substanzen

Antiviral AgentsSofosbuvirCarbamatesHeterocyclic Compounds, 4 or More RingsSulfonamidesCyclopropanesMacrocyclic CompoundsDrug Combinations

Autor:innen und Institutionen

  • Department of Pharmacotherapy, The Brooklyn Hospital Center, Brooklyn, NY, USA.
  • Department of Pharmacy, Monmouth Medical Center, Southern Campus, RWJBarnabas Health, Lakewood, NJ, USA.
  • Department of Pharmacy Practice, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, USA.
  • Program for AIDS Treatment and Health (PATH) Center, The Brooklyn Hospital Center, Brooklyn, NY, USA.

ORCID-Profile: Natasha Bhutani, Yoona Lee, Maria A Longo

Zitieren

APA

Bhutani, N., Lee, Y., Longo, M. A., & Berkowitz, L. (2025). Sustained Virologic Response Following a Shortened Course of Direct-Acting Antiviral Therapy in an HIV/HCV Co-Infected Patient With Previous Treatment Experience: A Case Report. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900251408942

Vancouver

Bhutani N, Lee Y, Longo MA, Berkowitz L. Sustained Virologic Response Following a Shortened Course of Direct-Acting Antiviral Therapy in an HIV/HCV Co-Infected Patient With Previous Treatment Experience: A Case Report. Journal of Pharmacy Practice. 2025. doi:10.1177/08971900251408942

BibTeX
@article{Bhutani2025,
  author = {Bhutani, Natasha and Lee, Yoona and Longo, Maria A and Berkowitz, Leonard},
  title = {Sustained Virologic Response Following a Shortened Course of Direct-Acting Antiviral Therapy in an HIV/HCV Co-Infected Patient With Previous Treatment Experience: A Case Report},
  journal = {Journal of Pharmacy Practice},
  year = {2025},
  doi = {10.1177/08971900251408942}
}
Kostenlos starten →